Pages that link to "Q30320077"

The following pages link to Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes (Q30320077):

Displaying 19 items.

• Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. (Q33372798) (← links)
• Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products (Q33595290) (← links)
• Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. (Q33649275) (← links)
• Suppression of Transforming Growth Factor-β Signaling Delays Cellular Senescence and Preserves the Function of Endothelial Cells Derived from Human Pluripotent Stem Cells (Q33722545) (← links)
• Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion (Q34478974) (← links)
• Cell-based therapies for diabetic complications (Q35070554) (← links)
• Cell invasion in the spheroid sprouting assay: a spatial organisation analysis adaptable to cell behaviour (Q35164714) (← links)
• Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? (Q37072018) (← links)
• Atherosclerosis as a disease of failed endogenous repair (Q37152177) (← links)
• Emerging hurdles in stem cell therapy for peripheral vascular disease (Q37246834) (← links)
• The promise of cell-based therapies for diabetic complications: challenges and solutions (Q37276042) (← links)
• Clinical implication of endothelial progenitor cells (Q37661456) (← links)
• Adult Stem Cells and Diseases of Aging (Q37711264) (← links)
• Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes (Q37858162) (← links)
• Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications (Q38315999) (← links)
• Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells (Q38858414) (← links)
• AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs' Dysfunction and Strengthened Anti-oxidant Capacity (Q39055132) (← links)
• Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes (Q42115221) (← links)
• A Uremic Solute, P-Cresol, Inhibits the Proliferation of Endothelial Progenitor Cells via the p38 Pathway (Q54575078) (← links)